Radiopharm Theranostics Limited American Depositary Shares (RADX) is a publicly traded Healthcare sector company. As of October 5, 2026, RADX trades at $1.04 with a market cap of $20.72M and a P/E ratio of 0.00. RADX moved -4.93% today. Year to date, RADX is -73.56%; over the trailing twelve months it is -75.30%. Its 52-week range spans $1.40 to $16.25. Rallies surfaces RADX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Radiopharm Theranostics Limited American Depositary Shares (RADX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. RADX moved -4.93% today.
| Metric | Value |
|---|---|
| Price | $1.04 |
| Market Cap | $20.72M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $16.25 |
| 52-Week Low | $1.40 |
| Volume | 21.25K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
RADX analyst coverage data. Average price target: $0.00.